Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Impact on QoL in Hormone-Independent Metastatic Prostate Cancer
NCT00003682Phase 3Terminated
- Sponsor
- Unicancer
- Start
- Oct 1998
- Primary completion
- Mar 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin in prostate cancer (PCa), sponsored by Unicancer. Started Oct 1998; status: terminated.
02
Drugs
doxorubicin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003682.